Implementation Grant Funding Opportunity Open
IMPORTANT: The grant program operates on a rolling basis and applications may be submitted at any time, with quarterly reviews.
Learn More
Implementation Grant Funding Opportunity Open
Qualifying* small and medium-sized US manufacturers, that received IAC or Combined Heat and Power Technical Assistance Partnership assessments between 2018 and 2024, can now apply for grants for implementation of assessment recommendations up 50% of qualifying* project costs with a maximum of $300,000 per manufacturer.
IMPORTANT: The grant program now operates on a rolling basis and applications may be submitted at any time through the year, with quarterly reviews.
*See Full Grant Solicitation for full qualification and selection details.
5
matching assessments| SIC | 2834 | Pharmaceutical Preparations |
|---|
| ID | Year | Products | Reccs | Plant Energy Costs | Recommended Savings |
|---|---|---|---|---|---|
| UD1038 | 2022 |
UD1038 | 2022
Pharmaceuticals
|
7 | $1,083,858 | $90,960 |
| UD1024 | 2020 |
UD1024 | 2020
Vivitrol, Aristada, Risperdal Consta, and Polymer
|
11 | $2,375,024 | $1,139,082 |
| UD0910 | 2014 |
UD0910 | 2014
Pharmaceutical Manufacturing and Development
|
12 | $4,306,094 | $841,066 |
| UD0803 | 2009 |
UD0803 | 2009
Pharmaceuticals
|
16 | $1,248,877 | $501,437 |
| UD0447 | 1994 |
UD0447 | 1994
heparin
|
6 | $254,138 | $13,222 |